Based On The Analysis Of The Financial Statements Of Kangmei Pharmaceutical Under The Harvard Analysis Framework

The analysis of financial statements is an important task for enterprise management,and it is also a basic means for enterprises to analyze and evaluate the financial situation and operating results.However,because financial fraud often occurs,the financial analysis and evaluation of the enterprise are unobjective,making the financial statements The analysis did not play its role.In recent years,Kangmei Pharmaceutical has caused an uproar in the market due to financial fraud.The Harvard analysis framework provides good guidance for the company's financial analysis from a new level,and creates a scientific financial analysis method for modern companies to correct the deficiencies of traditional financial analysis.The Harvard analysis framework uses strategic analysis methods,combined with the SWOT method and PEST theory,to analyze the internal and external environment of the enterprise,the advantages and disadvantages of the enterprise,as well as the opportunities and challenges facing,and to predict the development situation reasonably,providing the future development prospects of the enterprise Suggest.Based on the above background,the article focuses on the analysis of Kangmei Pharmaceutical's financial statements under the Harvard analysis framework.By referring to the Harvard analysis framework,an analysis framework for identifying fraudulent acts in financial reports of listed companies is constructed.Through investigation,it was found that during the development process of Kangmei Pharmaceutical,there were serious financial frauds in the financial reports published from 2016 to 2018,which violated the relevant provisions of the Securities Law.Judging from the situation of Kangmei Pharmaceutical's counterfeiting cases,it is mainly concentrated in Kangmei Pharmaceutical's.First,it makes false deposits through false bank statements;secondly,it uses the fake business vouchers to increase its revenue;finally,it uses the transfer of some funds to related parties.In the account,the company's stock transactions.Using these questions as an index,using the Harvard analysis framework,and based on Kangmei Pharmaceutical's periodic reports and announcements from 2014 to 2019,the company's strategy and financial situation are analyzed.Analysis of Kangmei Pharmaceutical's financial data,including fraudulent identification of the company's profitability and asset quality from three aspects of cash flow indicators,asset quality indicators and profit quality indicators,and evaluation analysis.By analyzing the status of the pharmaceutical industry and comparing with similar companies,the company's profitability and frauds are analyzed.Based on the data of strategic analysis,accounting analysis and financial analysis,the article organizes relevant information to analyze and study it,and through the prospect analysis during the entire research process,it is proposed that the enterprise should clarify the property rights relationship and determine the independent principal;strengthen internal control and improve the company The governance structure and emphasis on strengthening government supervision will help safeguard the vital interests of investors and the sustainable development of Chinese capital market.